{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:08:24Z","timestamp":1792728504446,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":288,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100004522","name":"Top Institute Pharma","doi-asserted-by":"crossref","award":["T4-214"],"award-info":[{"award-number":["T4-214"]}],"id":[{"id":"10.13039\/501100004522","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust","award":["WT 085733MA"],"award-info":[{"award-number":["WT 085733MA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.vaccine.2012.08.027","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T15:55:50Z","timestamp":1346255750000},"page":"6382-6388","source":"Crossref","is-referenced-by-count":15,"title":["Pre-existing virus-specific CD8+ T-cells provide protection against pneumovirus-induced disease in mice"],"prefix":"10.1016","volume":"30","author":[{"given":"Mary J.G.","family":"van Helden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.S.","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis P.J.","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gr\u00f6ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Topham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire J.P.","family":"Boog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk H.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar M.W.","family":"Zaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J.A.M.","family":"Sijts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2012.08.027_bib0005","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/CMR.17.2.390-412.2004","article-title":"Animal pneumoviruses: molecular genetics and pathogenesis","volume":"17","author":"Easton","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2012.08.027_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.027_bib0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population","volume":"89","author":"Chin","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.027_bib0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.027_bib0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.027_bib0030","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.027_bib0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2012.08.027_bib0040","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/S0264-410X(03)00355-4","article-title":"Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.08.027_bib0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1086\/517376","article-title":"Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults","volume":"177","author":"Falsey","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.027_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00148581-200406030-00004","article-title":"Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infection","volume":"6","author":"Fenton","year":"2004","journal-title":"Paediatr Drugs"},{"issue":"10","key":"10.1016\/j.vaccine.2012.08.027_bib0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197903083001004","article-title":"Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children","volume":"300","author":"Henderson","year":"1979","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2012.08.027_bib0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1513\/pats.200503-022AW","article-title":"Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system","volume":"2","author":"Braciale","year":"2005","journal-title":"Proc Am Thorac Soc"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2012.08.027_bib0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12026-007-0071-6","article-title":"Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"39","author":"Castilow","year":"2007","journal-title":"Immunol Res"},{"issue":"9","key":"10.1016\/j.vaccine.2012.08.027_bib0070","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4","article-title":"Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity","volume":"32","author":"Ostler","year":"2002","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2012.08.027_bib0075","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1521-4141(200208)32:8<2117::AID-IMMU2117>3.0.CO;2-C","article-title":"Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma","volume":"32","author":"Ostler","year":"2002","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.027_bib0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2249.1992.tb06482.x","article-title":"CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells","volume":"88","author":"Alwan","year":"1992","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.027_bib0085","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.168.3.1163","article-title":"Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus","volume":"168","author":"Cannon","year":"1988","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.027_bib0090","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI115362","article-title":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice","volume":"88","author":"Graham","year":"1991","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.vaccine.2012.08.027_bib0095","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/JVI.02313-07","article-title":"The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice","volume":"82","author":"Tregoning","year":"2008","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.08.027_bib0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/viro.2002.1382","article-title":"RSV-induced immunopathology: dynamic interplay between the virus and host immune response","volume":"295","author":"Varga","year":"2002","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2012.08.027_bib0105","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/eji.1830271233","article-title":"CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection","volume":"27","author":"Hussell","year":"1997","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.027_bib0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/vim.2009.0016","article-title":"Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease","volume":"22","author":"Stevens","year":"2009","journal-title":"Viral Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.027_bib0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.186.3.421","article-title":"Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection","volume":"186","author":"Srikiatkhachorn","year":"1997","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2012.08.027_bib0120","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1128\/JVI.76.9.4287-4293.2002","article-title":"Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells","volume":"76","author":"Bossert","year":"2002","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2012.08.027_bib0125","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1128\/JVI.79.14.9315-9319.2005","article-title":"Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha\/beta interferon responsiveness","volume":"79","author":"Lo","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.027_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.09.001","article-title":"The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention","volume":"105","author":"Rosenberg","year":"2005","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.027_bib0135","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1128\/JVI.02041-08","article-title":"Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease","volume":"83","author":"Buchholz","year":"2009","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.08.027_bib0140","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/JVI.01365-10","article-title":"Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo","volume":"85","author":"Heinze","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.027_bib0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2008.03.013","article-title":"Pneumonia virus of mice: severe respiratory infection in a natural host","volume":"118","author":"Rosenberg","year":"2008","journal-title":"Immunol Lett"},{"issue":"10","key":"10.1016\/j.vaccine.2012.08.027_bib0150","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.4049\/jimmunol.175.10.6597","article-title":"Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection","volume":"175","author":"Claassen","year":"2005","journal-title":"J Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2012.08.027_bib0155","doi-asserted-by":"crossref","first-page":"11619","DOI":"10.1128\/JVI.00375-08","article-title":"Role of T cells in virus control and disease after infection with pneumonia virus of mice","volume":"82","author":"Frey","year":"2008","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2012.08.027_bib0160","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.vaccine.2011.01.087","article-title":"Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV","volume":"29","author":"Kruijsen","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.027_bib0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4049\/jimmunol.179.1.201","article-title":"Early intrahepatic accumulation of CD8+ T cells provides a source of effectors for nonhepatic immune responses","volume":"179","author":"Polakos","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.027_bib0170","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/IAI.01134-07","article-title":"The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion","volume":"76","author":"Zaiss","year":"2008","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2012.08.027_bib0175","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.4049\/jimmunol.175.7.4735","article-title":"Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice","volume":"175","author":"Garvey","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.027_bib0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-7613(00)80161-2","article-title":"Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses","volume":"12","author":"Chen","year":"2000","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.027_bib0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm0102-54","article-title":"Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract","volume":"8","author":"Chang","year":"2002","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.vaccine.2012.08.027_bib0190","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.175.5.1221","article-title":"Extracellular processing of peptide antigens that bind class I major histocompatibility molecules","volume":"175","author":"Sherman","year":"1992","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2012.08.027_bib0195","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/JVI.67.7.4086-4092.1993","article-title":"Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells","volume":"67","author":"Kulkarni","year":"1993","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.027_bib0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4049\/jimmunol.0802270","article-title":"Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice","volume":"183","author":"Percopo","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.027_bib0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2007.06.002","article-title":"Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity","volume":"368","author":"Claassen","year":"2007","journal-title":"Virology"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2012.08.027_bib0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2007.07.011","article-title":"Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry","volume":"327","author":"Stevens","year":"2007","journal-title":"J Immunol Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:50:26Z","timestamp":1594601426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1201208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":42,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0264410X1201208X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.08.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}